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1131-80 Relation of Blood Pressure and Atheroscleroais Risk 
Factors With Thoracic Aortic Dimensions: A 
Population-Based Transesophageel Echocardiographlc 
Study 
Yorem Aomon. Bijoy K. Khandheria, Irene Meissner, Gary L. Schwartz, JoRean D. Sicks, 
Angela Fought, W. M. O'Fallon, David O. Wiebers, James B. Seward, A. J. Tajik, Mayo 
Clinic and Mayo Foundation, Rochester, Minnesota. 
Backoraund: The determinants of thoracic aortic dimensions have not been fully defined 
in the general population. Methods: Thoracic aortic dimensions (diameters at the sinuses 
of Valsalva [SV], ascending aorta [AA], aortic arch and descending aorta [DA]) were 
measured by transesophagesl echocardiogrephy in 373 subjects (median age 66 yr, 
range 51-101; 52% men) participating in a population-based study (Stroke Prevention: 
Assessment of Risk in a Community), who were free of significant aortic valve disease. 
The relationship between BP, additional atherosclerosis risk factors (including lipid lev- 
els) and aortic dimensions was examined. Results: Age, mate gender and body surface 
area (BSA) were significant determinants of aortic diameters, jointly accounting for 41%, 
31%, 38% and 47% of variability in size of SV, hA, arch and DA, respectively. Adjusting 
for age, gender and BSA: 1) Systolic BP was negatively associated with SV diameter 
(0.18 mm decrease ~0.09] per 10 mmHg; P=0.04) and pulse pressure was negatively 
associated with AA diameter (0.26 mm decrease ~0.12] per 10 mmHg; P=0.03); 2) BP 
was not related to arch size; 3) Diastolic BP and treatment with antihypertensive medica- 
tions (a possible surrogate of hypertension severity) were positively associated with DA 
diameter (0.31 mm increase [~0.15] per 10 mmHg increase in diastolic BP, P=-0.03; 0.66 
mm increase ~0.27] in treated subjects, P=0.02); 4) In addition to BP - higher HDL-cho- 
lesterol (and higher apo A-I), lower tdglyceddes and lower apo-B (i.e. an "anti-athero- 
genic" lipid profile) were associated with greater AA size; smoking was associated with 
greater arch size; diabetes was associated with greater DA size (all P values <0.05). 
However, each of these risk factors accounted for less than 2% of the variability in aortic 
dimensions (adjusting for age, gender and BSA). Conclusion~: Age, gender and body 
size are significant determinants of thoracic aortic dimensions. Higher BP and additionel 
atherosclerosis risk factors are associated with dilatation of distal, but not proximal, aortic 
segments, but the overall contribution of these atherosclerosis risk factors to aortic size is 
small. 
1131-81 Primary Snoring, Systemic Blood Pressure, and Arterial 
Distensibility in Children 
Yiu-fai Cheuno, Carrie K. Kwok, Daniel K. Ng, The University of l-long Kong, Hong Kong, 
People's Republic of China, Kwong Wah Hospital, l-long Kong, People's Republic of 
China. 
Background: Snoring, believed to represent beginning of the sleep-disordered breathing 
continuum, occurs commonly in children. Whilst obstructive sleep apnoea, the opposite 
extreme, is associated with hypertension, potential effects of snoring on vascular func- 
tions have not been studied. We assessed the effects of primary snoring in children on 
arterial compliance and btood pressure. 
Methods: Forty-two children with primary snoring, as defined by polysomnography dem- 
onstrating snoring but without apnoea or hypoventilation (apnoea-hypopnoea index of 1 
or less per hour), were studied at a mean of 11.8 (SD 3.8) years, while 154 healthy chil- 
dren aged 6-18 years were studied as a control group. Arterial distensibiltiy was 
assessed by measuring pulse wave velocity (PWV, inversely related to distensibility) in 
the brachio-radial arterial segment. Blood pressure (BP) was measured by Dinamap. 
Data from the two groups were expressed as z scores (mean±SE) and compared. 
Univariate analysis was performed to determine contribution of each covsriate to variabil- 
ity in PWV and systemic BP, while multiple regression was performed to identify determi- 
nants of PWV and BP. 
Results: Compared with controls (z score 0.00±0.08), children with primary snoring had 
higher z scores of PWV (0.78¢0.17, p<0.001 ), systolic BP (0.82±0,16, p<0.001 ), diastolic 
BP (0.87¢-0.17, p<0.001), mean BP (1.69±0.20, p<0.001), and a greater body mass 
index (21.1¢0.91 vs 17.8±0.24, p<0.001). Although univadata analysis showed signifi- 
cant contributions of each of body mass index (p=0.002), snoring (p<0.001) systolic 
(p=0.039), diastolic (p=0.009), and mean (p<0.001) BP to variability in PWV, multivariate 
analysis identified snoring (p=0.044) as the only significant determinant. On the other 
hand, both univariata and multivariate analyses showed that age (p<0.001), body mass 
index (p<0.001), PWV (p=0.031) and snoring (p<0.001) were significant determinants of 
mean systemic BP. 
Conclusions: Increased PWV, and hence reduced arterial distensibility, and increased BP 
occurred in children with primary snoring. These functional vascular abnormalities may 
increase cardiac afterload and prejudice later cardiovascular health. 
1131-82 Association Between Pulse Pressure end C-Reactive 
Protein Among Healthy U.S. Adults 
Jerome L. Abremson. Viola Vaccarino, Emory Univesrity School of Medicine, Atlanta, 
Georgia. 
Background: Evidence indicates that pulse pressure (PP) is positively associated with 
wear and tear of the artery wall and mononuclear cell adhesion. Such evidence suggests 
that elevations in PP may facilitate an inflammatory response which, in turn, might lead to 
initiation or progression of atherosclerosis and higher cardiovascular disease (CVD) risk. 
However, associations between PP and markers of systemic inflammation have not been 
investigated. 
Methods: We examined the relationship between PP and C-reactive protein (CRP), a 
marker of systemic inflammation, among 9,867 apparently healthy U.S. adults who par- 
ticipated in the Third National Health and Nutrition Examination Survey (NHANES III). 
The multivariable-edjusted association between PP and an elevated CRP level (defined 
as >= .66 mg/dL) was assessed by logistic regression. 
Results: A logistic regression model that adjusted for systolic blood pressure (SBP) , 
demographic factors, lipid levels, obesity, smoking status, alcohol consumption, and 
physical activity, showed that a 10 mm Hg increase in PP was associated with a statisti- 
cally significant 15% increase in the odds of having an elevated CRP level (odds ratio 
1.15; 95% CI 1.01-1.31; p = .04), When the same model was re-run controlling for dias- 
tolic blood pressure (DBP) instead of SBP, a 10 mm Hg increase in PP was associated 
with a significant 12% increase in the odds of having an elevated CRP level (odds ratio 
1.12; 95% CI 1.04-1.22; p < .01). SBP and DBP were not ratatad to CRP when PP was 
controlled for. 
Conclusion: Increasing levels of PP are significantly associated with higher odds of hav- 
ing an elevated CRP level among apparently healthy U.S. adults. Low-grade inflamma- 
tion may represent a mechanism through which pulse pressure increases CVD risk. 
1131-83 Angiotenain Converting Enzyme Inhibitors and 
Angiotenein Receptor Blockers in Hypertensive 
African-Americans 
vasilios Paoademetriou, Puneet Narayan, Peter Kokkinos, VA Medical Center & 
Georgetown Universi~ Washington, Dist. of Columbia. 
Background.African Americans (AA) with hypertension are less responsive to blockers 
of the rsnin angiotensin system than Caucasian patients. The relative efficacy of ACEI 
and ARBs and the extent of cross resistance to these agents has not been adequately 
studied. The present trial was designed to compare the response rates of the ACEI enal- 
april (E) to the ARB candesartan (C), to assess if resistance to E predicts resistance to C 
and the effect of combination of the two. 
Methods: A total of 50 AA patients (pts) with stage I-II hypertension were enrolled. Fol- 
lowing a 2-3 week washout period pts were randomly assigned to E 10 mg daily 
increased to 20 mg if blood pressure (BP) was not controlled or C 16 mg increased to 32 
mg daily. At the end of this pedod and after e second washout, pts were crossed to the 
other traatement. Non-responders to E&C entered a third phase using combination of E 
10 mg + C 16 mg increased to E 20 mg + C 32 mg daily. Responders were defined by a 
_>10mmHg reduction in systolic BP (SBP) or _>5mmHg in diastolic BP (DBP). 
Results: Of the 50 pts randomized, 44 completed this study (av age 60 yrs). Baseline 
BP averaged 148/100 mmHg, heart rate 74 BPM and body weight 204 tbs. Of these 44 
pts, 11 pts(25%) responded to E by SBP and 19 pts(43%) by DBP. Only 7 pts (16%) 
responded by both SBP & DBP, whereas 21 pts (48%) were non-responders. With C 
therapy of the same 44 pts 13 (29%) responded by SBP, 20 pts by DBP and 12 pts 
(27%) by both SBP & DBP (P<.04, compared to E). In contrast only 6 pts (14%) 
responded to both E&C by both SBP & DBP. Of the 11 pts who responded to E by SBP 
only 6 (54%) responded also to C and of the 19 E responders by DBP 12 (64%) 
responded to C. Similarly of the 13 responders to C by SBP, 8(61%) also responded to E 
and of the 20 responders by DBP 12(60%) responded to E. Of the 44 pts 10 (23%) were 
controlled (SBP<140 & DBP<90 mmHg) with C and 6 pts(14%)with E (P<,001). Of the 
non-rasponders to either E or C, 25% responded to the combination of the two. 
Conclusions: In AA patients with stage I-II hypertension:l) treatement with C resulted in 
slightly higher response and control rates than E ; 2) Over 40% of pts who responded to 
E did not respond to C and vice versa; 3) The combination of C & E offers additional anti- 
hypertensive effect. 
1131-84 Blood Pressure Control and Edema Rates in Older 
Patients With Hypertension and Oeteoarthr l t i s  
Following Treatment With COX-2 Specific Inhibitors 
Andrew Wheltorl, William B. White, John G. Fort, Johns Hopkins Universi~ Baltimore, 
Maryland, University of Connecticut School of Medicine, Farmington, Connecticut. 
Background: The effect of COX-2 specific inhibitors on SBP control and development of 
edema in hypertensive patients with osteoarthdtis was assessed in a randomized, dou- 
ble-blind trial. 
Methods: Hypertensive patients (N=1092) received either celecoxib 200 mg/d (n=549) 
or rofecoxib 25 mg/d (n=543) for 6 weeks. Changes from baseline in BP were determined 
in all patients. Changes in SBP and weight were evaluated in patients with significant 
edema. Significant edema was defined as change from baseline of 0-4+; initiate/increase 
medication to manage edema; increase of ±1 grade edema with 3% weight gain; or 
increase of _>2 grades edema with/witbout weight gain. 
Results: 62% patients were female, mean age 73 yrs. Significantly more mfecoxib 
patients than oelecoxib experienced clinically important increases in SBP at any time- 
point (14.9% vs 6.9%, P<0.001). New-onset or worsening edema occurred in signifi- 
cantly more patients in rafecoxib (25%) than calecoxib (18%) at any timepoint (P=-0.O08). 
For patients with significant edema, mean change in weight [cal: n= 26; 1.36.-t:1.9 vs rot: 
n=42; 2.42+2.2; /==-0.04] and in SBP [cel: 0.42+11.1 vs rof: 10.14±14.1; P=0,004] was 
significantly lower for celecoxib than rofecoxib. 
Conclusions: Mean changes from baseline in SBP were higher in the rofecoxib group 
than in the celecoxib group for all patients. Furthermore, mean changes in SBP and 
weight were significantly higher in rofecoxib than celecoxib subgroups with significant 
edema. 
Overall Change in mean SBP (±SEM), mm Hg 
Celecoxib (n=549) Rofecoxib (n=543) 
Week 1 -0.6±0.5 1.7±0.5" 
Week 2 0.2±0.5 3.3±0.5" 
Week 6 -0.5±0.5 3.0±0.5* 
*P<0.001 
